entity

Early AD

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Early AD: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1Connections
3Hypotheses
1Analyses
0Outgoing
1Incoming
1Experiments
2Debates

No AI portrait yet

Wiki Pages (3)

Knowledge base pages for this entity

Blood-Based Biomarker Panel for Early AD Detection

experiment · 817 words

Brain Connectivity-Targeted tACS Trial in Early AD

experiment · 595 words

Brain Connectivity-Targeted tACS Trial in Early AD

experiment · 589 words

Outgoing (0)

TargetRelationTypeStr
No outgoing edges

Incoming (1)

SourceRelationTypeStr
sTREM2associated_withprotein0.70

Targeting Hypotheses (3)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Real-time gamma-guided transcranial focused ultrasound targe 0.827 Alzheimer's disease Circuit-level neural dynamics in neurode
Gamma-Entrained P-tau217 Biomarker Cascades Optimize lncRNA- 0.431 molecular neurobiology View
GrimAge Acceleration as a Cell-Type-Resolved CSF Biomarker P 0.351 - Epigenetic clocks as biomarkers for Alzh

Mentioning Analyses (1)

Scientific analyses that reference this entity

Multi-modal Biomarker Panel Design for Early AD Detection

neurodegeneration | 2026-04-16 | 0 hypotheses

Experiments (1)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
tFUS Targeting EC-II SST Interneurons Restores Hippocampal-Prefrontal in_vivo Alzheimer's disease 0.744 0.48 hAPP-J20 mice (n=10/group x 3 proposed $110,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Association of CSF α-synuclein seed amplification assay positivity with disease [PMID:39428831] Tosun, Hausle, Thropp, Concha-Marambio, Alzheimer's & dementia : the j 2025 0
CSF markers of vascular injury correlate with tau and cognitive decline in early [PMID:41319164] Miners, Roy, Love Alzheimer's & dementia : the j 2025 0
Association of CSF α-synuclein seed amplification assay positivity with disease [PMID:39428831] Unknown Alzheimer's & dementia : the j 2025 0
CSF markers of vascular injury correlate with tau and cognitive decline in early [PMID:41319164] Unknown Alzheimer's & dementia : the j 2025 0
P-tau217 correlates with neurodegeneration in Alzheimer's disease, and targeting [PMID:38513667] Zhang D, Zhang W, Ming C, Gao X, Yuan H, Neuron 2024 0
The necroptosis cell death pathway drives neurodegeneration in Alzheimer's disea [PMID:38852117] Balusu S, De Strooper B Acta neuropathologica 2024 0
Sex Differences in Alzheimer's Disease. [PMID:37030962] Aggarwal, Mielke Neurologic clinics 2023 0
Sex Differences in Alzheimer's Disease. [PMID:37030962] Unknown Neurologic clinics 2023 0
DunedinPACE, a DNA methylation biomarker of the pace of aging. [PMID:35029144] Belsky DW, Caspi A, Corcoran DL Elife 2022 0
Epigenetic GrimAge acceleration and cognitive impairment in bipolar disorder. [PMID:35810614] Lima CNC, Suchting R, Scaini G Eur Neuropsychopharmacol 2022 0
Epigenetic clock: A promising biomarker and practical tool in aging. [PMID:36206857] Duan R, Fu Q, Sun Y Ageing Res Rev 2022 0
DNA methylation GrimAge version 2. [PMID:36516495] Lu AT, Binder AM, Zhang J Aging (Albany NY) 2022 0
CSF tau microtubule binding region identifies tau tangle and clinical stages of [PMID:33283854] Horie K, Barthélemy NR, Sato C, Bateman Brain : a journal of neurology 2021 0
CSF tau microtubule binding region identifies tau tangle and clinical stages of [PMID:33283854] Horie K, Barthélemy NR, Sato C, Bateman Brain : a journal of neurology 2021 0
Insulin Resistance and Diabetes Mellitus in Alzheimer's Disease. [PMID:34069890] Burillo J, Marqués P, Jiménez B, Gonzále Cells 2021 0
Impaired glymphatic function and clearance of tau in an Alzheimer's disease mode [PMID:32705145] Harrison IF, Ismail O, Machhada A, Colga Brain : a journal of neurology 2020 0
Impaired glymphatic function and clearance of tau in an Alzheimer's disease mode [PMID:32705145] Harrison IF, Ismail O, Machhada A, Colga Brain : a journal of neurology 2020 0
DNA methylation GrimAge strongly predicts lifespan and healthspan. [PMID:30669119] Lu AT, Quach A, Wilson JG Aging (Albany NY) 2019 0
Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in tra [PMID:17021169] ["Oakley, Holly", "Cole, Sarah L", "Loga The Journal of neuroscience : 2006 0
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road [PMID:12130773] ["Hardy, John", "Selkoe, Dennis J"] Science (New York, N.Y.) 2002 0

Debates (2)

Multi-agent debates referencing this entity

Can a multi-modal biomarker panel combining plasma proteins, neuroimaging featur

closed · Rounds: 4 · Score: 0.30 · 2026-04-21

Should clinical practice adopt multi-modal biomarker panels now, or wait for sin

closed · Rounds: 4 · Score: 0.70 · 2026-04-16

Related Research

Hypotheses and analyses mentioning Early AD in their description or question text

No additional research found